Holen Sie sich die Stockscreener-App
2.495
9.49%
0.225
Schlusskurs vom Vortag:
$2.27
Offen:
$2.31
24-Stunden-Volumen:
2.43M
Relative Volume:
0.93
Marktkapitalisierung:
$723.49M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-75.80M
KGV:
-7.1286
EPS:
-0.35
Netto-Cashflow:
$-68.07M
1W Leistung:
+16.69%
1M Leistung:
+38.85%
6M Leistung:
+8.06%
1J Leistung:
-23.99%
1-Tages-Spanne:
$2.31
$2.51
1-Wochen-Bereich:
$2.10
$2.51
52-Wochen-Spanne:
$1.54
$3.97
Nuvation Bio Inc Stock (NUVB) Company Profile
Firmenname
Nuvation Bio Inc
Sektor
Branche
Telefon
(415) 754-3517
Adresse
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Vergleichen Sie NUVB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
2.49 | 723.49M | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.26 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
609.33 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
651.56 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
260.35 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
256.18 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-23 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-03-27 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-02 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-04-06 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-03-08 | Eingeleitet | BTIG Research | Buy |
| 2021-03-08 | Eingeleitet | Cowen | Outperform |
| 2021-03-08 | Eingeleitet | Jefferies | Buy |
| 2021-03-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Nuvation Bio Inc Aktie (NUVB) Neueste Nachrichten
Invesco Ltd. Buys 7,344 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
LPL Financial LLC Grows Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present at The Citizens Life Sciences Conference - BioSpace
Nuvation Bio Inc [NUVB] Records 50-Day SMA of $1.98 - knoxdaily.com
Nuvation Bio Inc (NUVB) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Nuvation Bio Inc (NUVB)’s stock price range in the last year - uspostnews.com
Renaissance Technologies LLC Has $1.51 Million Stake in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Legal & General Group Plc Buys 62,877 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc [NUVB] Investment Guide: What You Need to Know - knoxdaily.com
An Overview of Nuvation Bio Inc (NYSE: NUVB)’s Stock Performance and Outlook - Marketing Sentinel
Russell Investments Group Ltd. Buys 15,791 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Cerity Partners LLC Makes New Investment in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio (NYSE:NUVB) Earns Market Outperform Rating from Analysts at JMP Securities - Defense World
Nuvation Bio (NYSE:NUVB) Earns Mkt Outperform Rating from Analysts at Citizens Jmp - Defense World
Analysts Set Nuvation Bio Inc. (NYSE:NUVB) PT at $7.83 - Defense World
Nuvation Bio Inc [NUVB] Records 200-Day SMA of $2.57 - knoxdaily.com
Nuvation Bio Inc Inc. (NUVB) Price Performance: A Technical Analysis Perspective - investchronicle.com
Investor’s Delight: Nuvation Bio Inc (NUVB) Closes Strong at 2.06, Up 4.04 - DWinneX
Citizens JMP sets Nuvation Bio stock at $6 target, Market Outperform - Investing.com Canada
Nuvation Bio (NUVB) Receives Outperform Rating with Promising Ca - GuruFocus
Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025 - BioSpace
Nuvation Bio Inc (NUVB): What Makes The Stock Good? - Marketing Sentinel
Geode Capital Management LLC Raises Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Federated Hermes Inc. Sells 349,503 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Is Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance
Wellington Management Group LLP Raises Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Vanguard Group Inc. - Defense World
Corebridge Financial Inc. Cuts Stake in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
American Century Companies Inc. Raises Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
KLP Kapitalforvaltning AS Acquires Shares of 43,500 Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple - Insider Monkey
Nuvation Bio CEO David Hung purchases $820,220 in company stock - Investing.com Australia
Nuvation Bio CEO David Hung purchases $820,220 in company stock By Investing.com - Investing.com South Africa
10 Stocks Under $10 that Will Triple - Insider Monkey
Institutional owners may take dramatic actions as Nuvation Bio Inc.'s (NYSE:NUVB) recent 8.8% drop adds to one-year losses - simplywall.st
Teacher Retirement System of Texas Increases Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference - BioSpace
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Nuvation Bio (NUVB) - The Globe and Mail
Nuvation Bio Inc (NYSE: NUVB) – An Analysis Is What You Need - stocksregister.com
Nuvation Bio (NYSE:NUVB) Reaches New 52-Week LowHere's Why - MarketBeat
Quantbot Technologies LP Decreases Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Quantbot Technologies LP Decreases Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - The AM Reporter
Nuvation Bio stock hits 52-week low at $1.7 amid market challenges - Investing.com
Swiss National Bank Buys 136,600 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Wedbush Reaffirms “Outperform” Rating for Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NYSE: NUVB) Has Great Upside Potential - Stocks Register
Nuvation Bio (NYSE:NUVB) Receives Outperform Rating from Wedbush - The AM Reporter
Nuvation Bio Inc. (NYSE:NUVB) Stock Position Boosted by Charles Schwab Investment Management Inc. - Defense World
Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025 - BioSpace
Finanzdaten der Nuvation Bio Inc-Aktie (NUVB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
2.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):